Peritoneal ultrafiltration for chronic congestive heart failure: Rationale, evidence and future

被引:34
作者
Mehrotra, R
Khanna, R
机构
[1] Harbor UCLA Med Ctr, Div Nephrol & Hypertens, Peritoneal Dialysis Program, Torrance, CA 90509 USA
[2] Univ Missouri, Div Nephrol, Columbia, MO USA
关键词
congestive heart failure; peritoneal dialysis; ultrafiltration;
D O I
10.1159/000047401
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peritoneal dialysis (PD) was the first dialytic therapy used to achieve euvolemia in individuals with refractory congestive heart failure. PD remains a viable therapy for the short-term management of refractory congestive heart failure, and fluid removal rates comparable to those obtained with the continuous extracorporeal therapies can be achieved. However, with advances in extracorporeal therapies, the role of PD in these situations is limited to those individuals in whom vascular access cannot be obtained or it extracorporeal therapies are not available. On the other hand, PD is the ultrafiltration therapy of choice for the long-term ambulatory management of individuals with refractory congestive heart failure, either as a palliative therapy or as a bridge to definitive surgery or transplantation. A reduction in hospitalization rates and an improvement in functional capacity can be expected under such circumstances; however, survival is unlikely to be affected. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 45 条
[1]  
BARRY KG, 1964, PEDIATR CLIN N AM, V11, P593
[2]   PERITONEAL DIALYSIS - CLINICAL EXPERIENCE [J].
BURNS, RO ;
HAGER, EB ;
MERRILL, JP ;
HENDERSON, LW .
NEW ENGLAND JOURNAL OF MEDICINE, 1962, 267 (21) :1060-&
[3]   CLINICAL AND HEMODYNAMIC RESULTS OF PERITONEAL DIALYSIS FOR SEVERE CARDIAC FAILURE [J].
CAIRNS, KB ;
PORTER, GA ;
KLOSTER, FE ;
BRISTOW, JD ;
GRISWOLD, HE .
AMERICAN HEART JOURNAL, 1968, 76 (02) :227-&
[4]  
CHEN TW, 1991, J AM SOC NEPHROL, V2, P1092
[5]  
CHOPRA MP, 1970, BRIT MED J, P77
[6]   Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum [J].
Devuyst, O ;
Nielsen, S ;
Cosyns, JP ;
Smith, BL ;
Agre, P ;
Squifflet, JP ;
Pouthier, D ;
Goffin, E .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (01) :H234-H242
[7]   CAPD to improve quality of life in patients with refractory heart failure [J].
Elhalel-Dranitzki, M ;
Rubinger, D ;
Moscovici, A ;
Haviv, YS ;
Friedlaender, MM ;
Silver, J ;
Popovtzer, MM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (12) :3041-3042
[8]  
Freida P, 1995, B DIAL PERIT, V5, P7
[9]  
Ganter G, 1923, MUENCHEN MED WOCHENS, V70, P1478
[10]   Newer peritoneal dialysis solutions [J].
Gokal, R .
ADVANCES IN RENAL REPLACEMENT THERAPY, 2000, 7 (04) :302-309